ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 984,93
-0,99%
Dow Jones
37 903,29
0,23%
DAX
17 932,17
-1,10%
Brent Oil
83,845
0,37%
Bitcoin
57 384,55
-1,46%
Registration Strip Icon for charts Inscrivez-vous pour des graphiques en temps réel, des outils d'analyse et des prix.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NYSE
  6. West Pharmaceutical Services Inc (WST)

  7. West Pharmaceutical Services Inc (WST) Actualités

WST West Pharmaceutical Services Inc

363,43
5,95 (1,66%)
02 Mai 2024 - Fermé
Retardé de 15 minutes
Nom Action Symbole Action Marché Type
West Pharmaceutical Services Inc WST NYSE Action ordinaire
  Variation Action Variation Action% Cours Dernier Dernier échange
Upgrade Icon
5,95 1,66% 363,43 02:00:00
Ouverture Plus Bas Plus Haut Prix de clôture Clôture Veille
356,40 355,65 368,46 363,43 357,48
plus d'informations sur les cotations »

Actualités Recentes

Date Heure Source Titre
30/4/202412:00PRNUSWest to Participate in Upcoming Investor Conference
25/4/202412:00PRNUSWest Announces First-Quarter 2024 Results and Declares..
11/4/202412:00PRNUSWest to Host First-Quarter 2024 Conference Call
01/3/202422:24EDGAR2Form PRE 14A - Other preliminary proxy statements
01/3/202419:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/2/202422:35EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/2/202422:30PRNUSWest to Participate in Upcoming Investor Conferences
27/2/202422:23EDGAR2Form 144 - Report of proposed sale of securities
27/2/202417:37EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/2/202400:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/2/202400:47EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/2/202400:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/2/202400:29EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/2/202400:22EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/2/202400:20EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/2/202400:16EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/2/202400:13EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/2/202400:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/2/202422:44EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
20/2/202412:00PRNUSWest Announces Second-Quarter 2024 Dividend
15/2/202413:51EDGAR2Form 8-K - Current report
15/2/202412:00PRNUSWest Announces Fourth-Quarter and Full-Year 2023 Results
07/2/202414:00PRNUSWest Named to Newsweek's America's Greatest Workplaces 2024..
01/2/202412:00PRNUSWest to Host Fourth-Quarter and Full-Year 2023 Conference..
24/1/202423:23EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
21/12/202318:54EDGAR2Form 4/A - Statement of changes in beneficial ownership of..
13/12/202322:36EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/12/202321:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/12/202312:00PRNUSWest Announces First-Quarter 2024 Dividend
06/12/202301:33EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/12/202321:46DJNWest Gets FDA 510(k) Clearance for Vial2Bag Advanced 13mm..
04/12/202321:00PRNUSWest Receives FDA 510(k) Clearance for Vial2Bag Advanced®..
30/11/202322:05EDGAR2Form 8-K - Current report
13/11/202313:00GLOBESotera Health Appoints Karen Flynn to Board of Directors
02/11/202318:37EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/11/202311:00PRNUSWest to Participate in Upcoming Investor Conferences
26/10/202322:26EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
26/10/202313:41EDGAR2Form 8-K - Current report
26/10/202312:00PRNUSWest Announces Third-Quarter 2023 Results, Updates Full-Year..
23/10/202312:00PRNUSWest to Attend and Showcase Industry Leadership in Packaging..
16/10/202312:00PRNUSWest to Present on Development of Large Volume Delivery..
12/10/202312:00PRNUSWest to Host Third-Quarter 2023 Conference Call
21/9/202322:33EDGAR2Form 8-K/A - Current report: [Amend]
07/9/202312:00PRNUSWest to Participate in Upcoming Investor Conference
01/9/202321:46EDGAR2Form 4 - Statement of changes in beneficial ownership of..
25/8/202301:24EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/8/202320:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/8/202322:52EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/8/202322:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/8/202320:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..

Dernières Valeurs Consultées

NYSE
WST
West Pharmaceutical Serv...
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés